Modulation of 2,6-dinitrotoluene genotoxicity by alachlor treatment of Fischer 344 rats. 1998

S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
Environmental Carcinogenesis Division, National Health and Environmental Effects Laboratory, US Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. george.elizabeth@epamail.epa.gov

Due to its widespread use as a preemergent herbicide, alachlor has been detected as a groundwater contaminant. The procarcinogen, 2,6-dinitrotoluene (DNT), a by-product of the munitions industry and a precursor to polyurethane production, is found in the manufacturing waste stream. This study explores the effect of alachlor treatment on the bioactivation of DNT by examining urine mutagenicity, intestinal enzymes, and hepatic DNA adducts to detect changes in metabolism. Five-week-old male rats were treated daily by gavage with 50 mg/kg of alachlor for up to 5 weeks while control animals received an equal volume of peanut oil. At 1, 3, and 5 weeks following the initial alachlor dose, animals were administered p.o. 75 mg/kg DNT or DMSO. Urine was collected for 24 hr in metabolism cages. Following incubation with sulfatase and beta-glucuronidase, urines were individually concentrated by C-18 solid phase extraction, dried under N2, and prepared for bioassay in Salmonella typhimurium strain TA98 with and without metabolic activation. Urine from peanut oil- and alachlor-treated rots was not mutagenic. Even though calf thymus DNA-alachlor adducts formed in vitro, no hepatic DNA adducts were detected in vivo in these two treatment groups. Interestingly, a significant increase in excretion of mutagenic urine from DNT-treated rats was observed following 3 weeks of alachlor treatment in the absence of S9 (690 +/- 130 vs. 339 +/- 28 revertants/ml) which corresponded to increased DNT-related hepatic DNA adduct formation (5.90 +/- 0.88 adducts/10(8) nucleotides vs. 10.56 x +/- 0.59 adducts/10(8) nucleotides [relative adduct level (RAL)]). Elevation in the production of mutagenic urine from control and treated animals was linked to increases in intestinal nitroreductase and beta-glucuronidase activities; however, the only significant alachlor-related effects were an increase in small intestinal 1-week beta-glucuronidase and 5-week dehydrochlorinase activities. The increased urine mutagenicity and hepatic DNA adduct formation indicates that alachlor has a transient effect on DNT bioactivation that apparently is unrelated to intestinal bioactivation.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D010573 Pesticide Residues Pesticides or their breakdown products remaining in the environment following their normal use or accidental contamination. Pesticide Residue,Residue, Pesticide,Residues, Pesticide
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D004136 Dinitrobenzenes Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrobenzene,Dinitrophenyl Compound,Dinitrophenyl Compounds,Dinitrotoluene,Dinitrotoluenes,Compound, Dinitrophenyl
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.

Related Publications

S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
January 1986, Toxicology and applied pharmacology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
August 2011, The Journal of toxicological sciences,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
October 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
May 1983, Toxicology and applied pharmacology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
June 1990, Cancer letters,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
July 1981, Toxicology and applied pharmacology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
November 1980, Toxicology and applied pharmacology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
January 1981, Drug metabolism and disposition: the biological fate of chemicals,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
January 1988, Veterinary pathology,
S E George, and J C Allison, and L R Brooks, and B T Eischen, and M J Kohan, and S H Warren, and L C King
January 1996, IARC monographs on the evaluation of carcinogenic risks to humans,
Copied contents to your clipboard!